2019 Central Retinal Vein Occlusion Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 170 pages | ID: 20A79B01D8AEN
VPAResearch

Abstracts

The global clinical trial report- “2019 Central Retinal Vein Occlusion Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Central Retinal Vein Occlusion. It presents in-depth analysis of Central Retinal Vein Occlusion clinical trials across markets and companies. The research work is for providing complete understanding into trends in Central Retinal Vein Occlusion.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Central Retinal Vein Occlusion clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Central Retinal Vein Occlusion

The research work is prepared through extensive and continuous research on Central Retinal Vein Occlusion trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Central Retinal Vein Occlusion patients are identified
• The report includes panorama of Central Retinal Vein Occlusion clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Central Retinal Vein Occlusion clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Central Retinal Vein Occlusion Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Central Retinal Vein Occlusion Clinical Trials by Region
  2.2.2 Average Enrollment of Central Retinal Vein Occlusion Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Central Retinal Vein Occlusion Treatment, 2019

3. REGION WISE CENTRAL RETINAL VEIN OCCLUSION CLINICAL TRIALS

3.1 Asia Pacific Central Retinal Vein Occlusion Clinical Trials by Country
3.2 Europe Central Retinal Vein Occlusion Clinical Trials by Country
3.3 North America Central Retinal Vein Occlusion Clinical Trials by Country
3.4 Middle East and Africa Central Retinal Vein Occlusion Clinical Trials by Country
3.5 South and Central America Central Retinal Vein Occlusion Clinical Trials by Country

4. CENTRAL RETINAL VEIN OCCLUSION CLINICAL TRIAL TRENDS

4.1 Start Year wise Central Retinal Vein Occlusion Clinical Trials
4.2 Phase wise Central Retinal Vein Occlusion Clinical Trials
4.3 Trial Status wise Central Retinal Vein Occlusion Clinical Trials
4.4 Trial Type wise Central Retinal Vein Occlusion Clinical Trials

5. CENTRAL RETINAL VEIN OCCLUSION AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Central Retinal Vein Occlusion Trials by Year
5.2 Average Enrollment in Central Retinal Vein Occlusion Trials by Phase
5.3 Average Enrollment in Central Retinal Vein Occlusion Trials by Status
5.4 Average Enrollment in Central Retinal Vein Occlusion Trials by Type of Trial

6. COMPANIES PARTICIPATING IN CENTRAL RETINAL VEIN OCCLUSION CLINICAL TRIALS

6.1 Central Retinal Vein Occlusion Trials by Sponsor Type
6.2 Central Retinal Vein Occlusion Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Central Retinal Vein Occlusion Trials- Phase
7.2 Central Retinal Vein Occlusion Trials- Phase
7.3 Central Retinal Vein Occlusion Trials- Phase
7.4 Central Retinal Vein Occlusion Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Central Retinal Vein Occlusion Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Figure 5: Europe – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Figure 7: North America – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Figure 9: Central Retinal Vein Occlusion Clinical Trials by Phase
Figure 10: Central Retinal Vein Occlusion Clinical Trials by Trial Status
Figure 11: Central Retinal Vein Occlusion Clinical Trials by Type
Figure 12: Central Retinal Vein Occlusion Clinical Trials by Sponsor Type
Figure 13: Central Retinal Vein Occlusion Clinical Trials by Leading Sponsors
Figure 14: Central Retinal Vein Occlusion Average Enrollment by Phase
Figure 15: Central Retinal Vein Occlusion Average Enrollment by Trial Status
Figure 16: Central Retinal Vein Occlusion Average Enrollment by Type
Figure 17: Central Retinal Vein Occlusion- Average Enrolment by Type of Sponsors
Figure 18: Central Retinal Vein Occlusion- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Central Retinal Vein Occlusion Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Table 5: Europe – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Table 7: North America – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Central Retinal Vein Occlusion Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Central Retinal Vein Occlusion Average Enrollment by Phase
Table 15: Central Retinal Vein Occlusion Average Enrollment by Trial Status
Table 16: Central Retinal Vein Occlusion Average Enrollment by Type
Table 17: Central Retinal Vein Occlusion- Average Enrolment by Type of Sponsors
Table 18: Central Retinal Vein Occlusion- Enrolment by Leading Sponsors